StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Cabaletta Bio, Inc.
NasdaqGS:CABA
Sector
Industries
Location
Market Cap
USD 146.61 M
Share Price
USD 1.63
Avg Daily Volume
1,378,758
Change (1 day)
1.88%
Change (1 year)
-78.41%
Change (YTD)
-28.19%
Cabaletta Bio, Inc. Market Capitalization on July 03, 2025: USD 146.61 M
Cabaletta Bio, Inc. Market Capitalization is USD 146.61 M on July 03, 2025, a -60.51% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Cabaletta Bio, Inc. 52-week low Market Capitalization is USD 405.14 M on July 03, 2025, which is 176.34% above the current Market Capitalization.
-
Cabaletta Bio, Inc. 52-week low Market Capitalization is USD 52.77 M on July 03, 2025, which is -64.00% below the current Market Capitalization.
-
Cabaletta Bio, Inc. average Market Capitalization for the last 52 weeks is USD 171.96 M.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Siemens Healthineers AG
USD 55.00
SHL.DE
-0.17
-0.31%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Key Data
| Date | Market Capitalization | Share Price | Share Price | Price to Earnings Ratio (P/E) |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Siemens Healthineers AG
USD 55.00
SHL.DE
-0.17
-0.31%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%